Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer

By Koliadi Anthoula   Nilsson Cecilia   Holmqvist Marit   Holmberg Lars   de La Torre Manuel   Wärnberg Fredrik   Fjällskog Marie-Louise  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 816-820

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of aromatase protein expression in axillary node negative breast cancer

By Lu Jingsong   Li Hecheng   Cao Daocheng   Di Genhong   Wu Jiong   Sheng Kunwei   Han Qixia   Shen Zhenzhou   Shao Zhiming  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 6, 2007-06 ,pp. : 401-409

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of cyclin E expression in breast cancer: a meta-analysis

By Gao Sheng   Ma Jing-Jing   Lu Cheng  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3423-3430

Springer Publishing Company

Access to resources Recommend Favorite

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

By Kute T.E.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 1, 1998-01 ,pp. : 9-16

Springer Publishing Company

Access to resources Recommend Favorite

Physical activity and prostate gene expression in men with low-risk prostate cancer

By Magbanua Mark   Richman Erin   Sosa Eduardo   Jones Lee   Simko Jeff   Shinohara Katsuto   Haqq Christopher   Carroll Peter   Chan June  

Cancer Causes and Control, Vol. 25, Iss. 4, 2014-04 ,pp. : 515-523

Springer Publishing Company

Access to resources Recommend Favorite